{"id":7387,"date":"2021-12-16T07:57:34","date_gmt":"2021-12-16T12:57:34","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/bivalirudin-cas-128270-60-0-ist-ein-antikoagulans-fuer-die-laborforschung\/"},"modified":"2021-12-16T07:57:34","modified_gmt":"2021-12-16T12:57:34","slug":"bivalirudin-cas-128270-60-0-ist-ein-antikoagulans-fuer-die-laborforschung","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/de\/product\/bivalirudin-cas-128270-60-0-ist-ein-antikoagulans-fuer-die-laborforschung\/","title":{"rendered":"Bivalirudin CAS 128270-60-0 ist ein Antikoagulans f\u00fcr die Laborforschung"},"content":{"rendered":"<h2><strong>Bivalirudin CAS 128270-60-0 ist ein Antikoagulans f\u00fcr die Laborforschung<\/strong><\/h2>\n<p>Produktname: Bivalirudin<br \/>\nSynonyme: Bivalirudin, TFA;BIVALIRUDIN;BIVALIRUDIN TRIFLUORACETATE;BITTERMELONP.E;Menschliches Bivalirudin;DPHE-PRO-ARG-PRO-GLY-GLY-GLY-GLY-ASN-GLY-ASP- PHE-GLU-GLU-LLE-PRO-GLU-GLU-TYR-LEU;Bivalirudinacetat;Bivalirudin BG 8967, Hirulog, Hirulog I<br \/>\nCAS: 128270-60-0<br \/>\nMF: C98H138N24O33<br \/>\nMW: 2180.29<br \/>\nEINECS: 274-570-6<br \/>\nProduktkategorien: API;Proteine;Peptid<br \/>\nMol Datei: 128270-60-0.mol<\/p>\n<p>Bivalirudin ist eine Art synthetischer neuartiger Antikoagulanzien. Es ist der direkte, spezifische und reversible Thrombin-Inhibitor. Es wurde urspr\u00fcnglich vom Schweizer Basset (Biogen) entwickelt. Dann wurde es an die United States Medicines Company \u00fcbertragen und im Jahr 2000 in den USA zur Vermarktung zugelassen. Sein gerinnungshemmender Inhaltsstoff ist eine Art von 20 Peptiden, die aus Hirudin gewonnen werden. Bivalirudin kann spezifisch an die katalytische Stelle und die Anionenbindungsstelle binden, sei es Thrombin, das sich im Blutkreislauf befindet, oder thrombusgebundenes Thrombin, wodurch die Thrombinaktivit\u00e4t direkt gehemmt wird. Und seine Rolle zeichnet sich durch kurze, reversibel aus. Fr\u00fche klinische Studien zeigen, dass die gerinnungshemmende Behandlung von Bivalirudin gut ist. Und die H\u00e4ufigkeit von Blutungen ist gering. Daher ist seine Anwendung sicherer als die herk\u00f6mmliche Heparintherapie. Es wird haupts\u00e4chlich zur Vorbeugung von angioplastischen interventionellen Behandlungen von isch\u00e4mischen Komplikationen bei instabiler Angina pectoris vor und nach verwendet. <\/p>\n<p> <strong>Bivalirudin CAS 128270-60-0 Chemische Eigenschaften<\/strong><br \/>\n Dichte 1,52 \u00b1 0,1 g\/cm3 (vorhergesagt)<br \/>\nSpeichertemp. -20\u00b0C<br \/>\nFormpulver<br \/>\nFarbe wei\u00df bis cremefarben<br \/>\nInChIKey OIRCOABEOLEUMC-GEJPAHFPSA-N<\/p>\n<p> <strong>Verwendungen von Bivalirudin CAS 128270-60-0<\/strong><br \/>\nAntikoagulans; antithrombotisch.<\/p>\n<p>Biluvudin ist ein synthetisches Antikoagulans, ein 20-Peptid-Analogon von Hirudin, das im Jahr 2000 in den USA zur Vermarktung zugelassen wurde. Bivalirudin bindet spezifisch an die katalytische Stelle von Thrombin und die anionische externe Bindungsstelle , die die Aktivit\u00e4t von Thrombin direkt hemmt und dadurch die durch Thrombin katalysierten und induzierten Reaktionen hemmt, und ihre Wirkung ist reversibel. Bivalirudin wird haupts\u00e4chlich als Antikoagulans f\u00fcr die elektive perkutane Koronarintervention (PCI) bei Erwachsenen verwendet.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Produktname: Bivalirudin<br \/>\nCAS: 128270-60-0<br \/>\nMF: C98H138N24O33<br \/>\nMW: 2180.29<br \/>\nEINECS: 274-570-6<br \/>\nMol Datei: 128270-60-0.mol<\/p>\n","protected":false},"featured_media":2270,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[409],"product_tag":[2389],"class_list":{"0":"post-7387","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-blut-und-vaskulaeres-peptid","7":"product_tag-bivalirudin-cas-128270-60-0-is-an-anticoagulant-for-lab-research-de","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/product\/7387","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/comments?post=7387"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/media\/2270"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/media?parent=7387"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/product_brand?post=7387"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/product_cat?post=7387"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/product_tag?post=7387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}